DC Advisory advises Iskus Health on its sale to DCC plc
Background
- Iskus Health specializes in the marketing, sales and distribution of clinically differentiated single use, sterile, medical and surgical devices
- Iskus Health primarily focuses on the acute hospital market, with products used in operating theatres, intensive care, radiology, renal, emergency and other specialist departments
- DCC plc is a leading Irish international sales, marketing and support services group. Headquartered in Dublin, DCC plc operates across three sectors: Energy, Healthcare, and Technology
Process
- DC Advisory acted as the exclusive transaction advisor to the shareholders of Iskus Health on its sale to DCC plc
- DC Advisory led a targeted sales process, leveraging its deep knowledge of the healthcare distribution sector
Outcome
- DCC plc agreed to acquire Iskus Health in September 2024
- The transaction closed on 29th November. The financial terms of the transaction were not disclosed
- This transaction further illustrates DC Advisory’s expertise in the healthcare distribution sector
"Iskus Health is a highly regarded company in its sector. DCC plc is the ideal partner for the Company and both parties will benefit from complementary offerings. It was great working with Alan, Michael and Stuart on this transaction. We would like to wish Iskus and DCC plc all the best for the future".
Date
Sectors
- Healthcare
Deal type
- M&A Advisory
Deal locations
Deal team
Managing Director, DC Advisory Ireland
Director
Senior Manager, DC Advisory Ireland
UN SDG Activity
Actions
Disclaimer
For more information, please see our transaction disclaimer
For important information regarding testimonials, please see our disclaimer.